HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 550,000 Value ($000) $594 Avg Close — Range —
Q3 2025
Shares 2,586,000 Value ($000) $2,963 Avg Close — Range —
Q2 2025
Shares 2,586,000 Value ($000) $2,574 Avg Close — Range —
Q1 2025
Shares 2,586,000 Value ($000) $2,738 Avg Close — Range —
Q4 2024
Shares 2,586,000 Value ($000) $2,470 Avg Close — Range —
Q3 2024
Shares 2,586,000 Value ($000) $2,591 Avg Close — Range —
Q2 2024
Shares 2,586,000 Value ($000) $2,465 Avg Close — Range —
Q1 2024
Shares 2,586,000 Value ($000) $2,293 Avg Close — Range —
Q4 2023
Shares 2,768,000 Value ($000) $2,393 Avg Close — Range —
Q3 2023
Shares 2,768,000 Value ($000) $2,343 Avg Close — Range —
Q2 2023
Shares 3,768,000 Value ($000) $3,140 Avg Close — Range —
Q1 2023
Shares 3,962,000 Value ($000) $3,354 Avg Close — Range —
Q4 2022
Shares 3,352,000 Value ($000) $3,264 Avg Close — Range —
Q3 2022
Shares 4,250,000 Value ($000) $3,613 Avg Close — Range —
Q2 2022
Shares 1,000,000 Value ($000) $883 Avg Close — Range —